NuGen Medical Devices Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CAD 0.022549 million compared to CAD 0.058751 million a year ago. Net loss was CAD 2.39 million compared to CAD 1.41 million a year ago. Basic loss per share from continuing operations was CAD 0.015.
For the six months, sales was CAD 0.046925 million compared to CAD 0.126366 million a year ago. Net loss was CAD 4.51 million compared to CAD 2.91 million a year ago. Basic loss per share from continuing operations was CAD 0.031.